Pharmacogenomics (PGx) Screening

Pharmacogenomics (PGx) screening is a breakthrough in preventive medicine that analyzes CYP450 enzyme variants responsible for drug metabolism in the liver. This test helps physicians identify the most effective medications for each patient based on their unique genetic makeup, reducing the trial-and-error approach and protecting patients from dangerous drug reactions, particularly in cardiology, psychiatry, and pain management.